“Anti-Amyloid Monoclonal Antibodies and Amyloid-Related Imaging Abnormalities in Early Alzheimer Disease”, CRNN, vol. 9, no. 1, pp. 41–48, Aug. 2026, doi: 10.5281/zenodo.22310607.